|
|
| Line 1: |
Line 1: |
| | __NOTOC__ |
| | {{Prolactinoma}} |
| {{CMG}} | | {{CMG}} |
| {{Prolactinoma}}
| | |
| | Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. |
| | |
| ==Overview== | | ==Overview== |
| A '''prolactinoma''' is a [[benign]] [[tumor]] ([[adenoma]]) of the '''[[pituitary gland]]''' that produces a [[hormone]] called [[prolactin]]. It is the most common type of [[pituitary tumor]]. Symptoms of prolactinoma are caused by too much prolactin in the blood ([[hyperprolactinemia]]) or by pressure of the tumor on surrounding tissues.]
| |
| == Pregnancy and Oral Contraceptives ==
| |
| If a woman has a small prolactinoma, there is no reason that she cannot conceive and have a normal pregnancy after successful medical therapy. The pituitary enlarges and prolactin production increases during normal pregnancy in women without pituitary disorders. Women with prolactin-secreting tumors may experience further pituitary enlargement and must be closely monitored during pregnancy. However, damage to the pituitary or eye nerves occurs in less than one percent of pregnant women with prolactinoma. In women with large tumors, the risk of damage to the pituitary or eye nerves is greater, and some doctors consider it as high as 25%. If a woman has completed a successful pregnancy, the chances of her completing further successful pregnancies are extremely high.
| |
|
| |
|
| A woman with a prolactinoma should discuss her plans to conceive with her physician, so she can be carefully evaluated prior to becoming pregnant. This evaluation will include a magnetic resonance imaging (MRI) scan to assess the size of the tumor and an eye examination with measurement of visual fields. As soon as a patient is pregnant, her doctor will usually advise that she stop taking bromocriptine or cabergoline, the common treatments for prolactinoma. Most endocrinologists see patients every two months throughout the pregnancy. The patient should consult her endocrinologist promptly if she develops symptoms--particularly headaches, visual changes, nausea, vomiting, excessive thirst or urination, or extreme lethargy. Bromocriptine or cabergoline treatment may be renewed and additional treatment may be required if the patient develops symptoms from growth of the tumor during pregnancy.
| | ==Natural History== |
|
| |
|
| At one time, oral contraceptives were thought to contribute to the development of prolactinomas. However, this is no longer thought to be true. Patients with prolactinoma treated with bromocriptine or cabergoline may also take oral contraceptives. Similarly, post-menopausal estrogen replacement is safe in patients with prolactinoma treated with medical therapy or surgery.
| | ==Complications== |
| == Osteoporosis Risk == | | |
| [[Hyperprolactinemia]] can cause reduced [[estrogen]] production in women and reduced [[testosterone]] production in men. Although estrogen/testosterone production may be restored after treatment for hyperprolactinemia, even a year or two without estrogen/testosterone can compromise bone strength, and patients should protect themselves from osteoporosis by increasing exercise and [[calcium]] intake through diet or supplementation, and by avoiding smoking. Patients may want to have bone density measurements to assess the effect of estrogen/testosterone deficiency on bone density. They may also want to discuss testosterone/estrogen replacement therapy with their physician.
| | === Prognosis === |
| == Prognosis == | |
| People with microprolactinoma generally have an excellent prognosis. In 95% of cases the tumor will not show any signs of growth after a 4 to 6 year period. | | People with microprolactinoma generally have an excellent prognosis. In 95% of cases the tumor will not show any signs of growth after a 4 to 6 year period. |
|
| |
|
| Line 17: |
Line 17: |
|
| |
|
| == References == | | == References == |
| | | {{Reflist|2}} |
|
| |
|
| {{WikiDoc Help Menu}} | | {{WikiDoc Help Menu}} |
| Line 26: |
Line 26: |
| [[Category:Oncology]] | | [[Category:Oncology]] |
| [[Category:Mature chapter]] | | [[Category:Mature chapter]] |
| | [[Category:Needs content]] |
|
Prolactinoma Microchapters
|
|
|
|
Home
|
|
|
|
Patient Information
|
|
|
|
Overview
|
|
|
|
Historical Perspective
|
|
|
|
Classification
|
|
|
|
Pathophysiology
|
|
|
|
Causes
|
|
|
|
Differentiating Prolactinoma from other Diseases
|
|
|
|
Epidemiology and Demographics
|
|
|
|
Risk Factors
|
|
|
|
Screening
|
|
|
|
Natural History, Complications and Prognosis
|
|
|
|
Diagnosis
|
|
|
|
History and Symptoms
|
|
|
|
Physical Examination
|
|
|
|
Laboratory Findings
|
|
|
|
ECG
|
|
|
|
X-ray
|
|
|
|
Ultrasound
|
|
|
|
CT
|
|
|
|
MRI
|
|
|
|
Other Imaging Findings
|
|
|
|
Other Diagnostic Studies
|
|
|
|
Treatment
|
|
|
|
Medical Therapy
|
|
|
|
Surgery
|
|
|
|
Primary Prevention
|
|
|
|
Secondary Prevention
|
|
|
|
Cost-Effectiveness of Therapy
|
|
|
|
Future or Investigational Therapies
|
|
|
|
Case Studies
|
|
|
|
Case #1
|
|
|
|
Prolactinoma natural history, complications, and prognosis On the Web
|
|
|
|
Most recent articles
|
|
|
|
Most cited articles
|
|
|
|
Review articles
|
|
|
|
CME Programs
|
|
|
|
Powerpoint slides
|
|
|
|
Images
|
|
|
|
American Roentgen Ray Society Images of Prolactinoma natural history, complications, and prognosis
- All Images
- X-rays
- Echo & Ultrasound
- CT Images
- MRI
|
|
|
|
Ongoing Trials at Clinical Trials.gov
|
|
|
|
US National Guidelines Clearinghouse
|
|
|
|
NICE Guidance
|
|
|
|
FDA on Prolactinoma natural history, complications, and prognosis
|
|
|
|
CDC on Prolactinoma natural history, complications, and prognosis
|
|
|
|
Prolactinoma natural history, complications, and prognosis in the news
|
|
|
|
Blogs on Prolactinoma natural history, complications, and prognosis
|
|
|
|
Directions to Hospitals Treating Prolactinoma
|
|
|
|
Risk calculators and risk factors for Prolactinoma natural history, complications, and prognosis
|
|
|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Natural History
Complications
Prognosis
People with microprolactinoma generally have an excellent prognosis. In 95% of cases the tumor will not show any signs of growth after a 4 to 6 year period.
Macroprolactinomas often require more aggressive treatment otherwise they may continue to grow. There is no way to reliably predict the rate of growth, as it is different for every individual. Regular monitoring by a specialist to detect any major changes in the tumor is recommended.
References
Template:WikiDoc Sources